This chapter deals with an overall view of nanoparticulate systems opportunately engineered with antibodies for the delivery of active substance to the Central Nervous System. Concordantly to this aim, a brief introduction of the rationale undergoing the nanoparticulate approach to the brain targeting has been developed. Nanoparticles, liposomes and solid lipid nanoparticles, representing the most widely studied carriers for drug delivery and targeting, have been reviewed in their application to CNS targeting. In particular, antibody-mediated targeting represent one of the best choices in order to engineer and superficially modify the carriers, to finally target the therapeutic goal. Amongst the receptors to be usefully used for translocation into the CNS, the transferrin and insulin receptors seem to be the most selective systems for an active transcytosis of antibody-engineered nanosystems across the the Blood Brain Barrier.

Immunonanosystems to CNS pathologies: State of the art / Tosi, Giovanni; Ruozi, Barbara; Badiali, Luca; Bondioli, Lucia; Belletti, Daniela; Forni, Flavio; Vandelli, Maria Angela. - STAMPA. - 3:(2012), pp. 107-168. [10.4032/9789814267359]

Immunonanosystems to CNS pathologies: State of the art

TOSI, Giovanni;RUOZI, Barbara;BADIALI, Luca;BONDIOLI, Lucia;BELLETTI, Daniela;FORNI, Flavio;VANDELLI, Maria Angela
2012

Abstract

This chapter deals with an overall view of nanoparticulate systems opportunately engineered with antibodies for the delivery of active substance to the Central Nervous System. Concordantly to this aim, a brief introduction of the rationale undergoing the nanoparticulate approach to the brain targeting has been developed. Nanoparticles, liposomes and solid lipid nanoparticles, representing the most widely studied carriers for drug delivery and targeting, have been reviewed in their application to CNS targeting. In particular, antibody-mediated targeting represent one of the best choices in order to engineer and superficially modify the carriers, to finally target the therapeutic goal. Amongst the receptors to be usefully used for translocation into the CNS, the transferrin and insulin receptors seem to be the most selective systems for an active transcytosis of antibody-engineered nanosystems across the the Blood Brain Barrier.
Nanotechnology in Health Care
9789814267212
Pan Stanford Publishing
SINGAPORE
Immunonanosystems to CNS pathologies: State of the art / Tosi, Giovanni; Ruozi, Barbara; Badiali, Luca; Bondioli, Lucia; Belletti, Daniela; Forni, Flavio; Vandelli, Maria Angela. - STAMPA. - 3:(2012), pp. 107-168. [10.4032/9789814267359]
Tosi, Giovanni; Ruozi, Barbara; Badiali, Luca; Bondioli, Lucia; Belletti, Daniela; Forni, Flavio; Vandelli, Maria Angela
File in questo prodotto:
File Dimensione Formato  
Chapter 3_rev proof G Tosi.pdf

non disponibili

Tipologia: Post-print dell'autore (bozza post referaggio)
Dimensione 639.66 kB
Formato Adobe PDF
639.66 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/648458
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact